लोड हो रहा है...

Prognostic Biomarkers for Response to VEGF Targeted Therapy for Renal Cell Carcinoma

Our improved understanding of renal carcinoma disease biology over the past three decades has led to the discovery and FDA-approval of five novel therapies targeting specific molecules in the VEGF biochemical pathway. In order to properly select patients who will receive maximal therapeutic benefit...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Urol Clin North Am
मुख्य लेखकों: Winer, Andrew G., Motzer, Robert J., Hakimi, A. Ari
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864362/
https://ncbi.nlm.nih.gov/pubmed/26614032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ucl.2015.08.009
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!